Fundraising FoxEPIC VENTURES — 2026 Investments
4 investments dated 2026 · listed companies and verified rows first · show all
Calycia Bioscience is a biotechnology company developing engineered macrophage cell therapies delivered locally into the brain to target aggressive solid tumors of the central nervous system.
BiotechDeep TechHealthtechSalt Lake City, US
GetWhys enriches AI content generation and go-to-market tools with insights from real buyer interviews to validate messaging and campaigns.
AI & Machine LearningMarketing TechBoise, US
Philippe Boutros(CEO, President, Secretary)inViet Phan(Chief Technology Officer)inTyler Honsinger(Chief Product Officer)in
BoardJohn Garrett(Director)David Bluestone(Director)
Co-investorsNext Frontier CapitalCapital ElevenPortland Seed FundTuesday Capital
Uptiq builds pre-built, domain-trained AI agents that automate operational work in banking and lending—covering prospecting, onboarding, underwriting, credit decisioning, risk monitoring, and client engagement.
AI & Machine LearningEnterprise SoftwareFintechMckinney, US
Snehal Fulzele(Executive Officer, Director)inGanapathi Palanipandian(Director)
BoardNnamdi Okike(Director)inMichael Walsh(Director)
Co-investors645 VenturesCota CapitalCurql Collective, LLCEvolution VenturesHourglass Venture PartnersSilverton Partners+8 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.